Capmatinib (INC280 INCB28060) is a potent, orally active, selective, and ATP competitive c-Met kinase inhibitor (IC50=0.13 nM). Cap matinib can inhibit phosphorylation of c-MET as well as c-MET pathway downstream effectors such as ERK1/2, AKT, FAK, 1 * 100 mg
Catalog # MDEXHY-13404
Supplier: MEDCHEMEXPRESS
Frequently Bought Together